ARTICLE | Product Development
COVID-19: Quantifying the growing threat to clinical operations outside of China
As COVID-19 expands in Italy and South Korea, the threat to MNCs’ clinical operations is growing
March 5, 2020 10:45 PM UTC
Updated on Mar 6, 2020 at 5:14 PM UTC
As COVID-19 cases rise outside China, the crisis threatens to delay clinical trial operations in a growing number of countries, with South Korea and Italy top areas for concern.
Regions with high COVID-19 infection rates represent a high risk for clinical trials. Restrictions on travel and transport of APIs, as well as diversion of hospital staff and resources to infected patients, could seriously hamper trial operations as well as recruitment (see “Hidden Consequences of COVID-19”)...